{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:50:19Z","timestamp":1793494219196,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"DOI":"10.1038\/s41586-026-11142-x","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:03:29Z","timestamp":1791385409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A gut microbial odd-chain fatty acid alleviates atherosclerosis in mice"],"prefix":"10.1038","author":[{"given":"Chao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7492-0141","authenticated-orcid":false,"given":"Gan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2757-6742","authenticated-orcid":false,"given":"Mingwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaining","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxiong","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2443-5383","authenticated-orcid":false,"given":"Zepeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiahong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-9965","authenticated-orcid":false,"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5598-5308","authenticated-orcid":false,"given":"Lei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-6315","authenticated-orcid":false,"given":"Xiangyu","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-9870","authenticated-orcid":false,"given":"Xiaoyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1706-6324","authenticated-orcid":false,"given":"Wenjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"11142_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie, Z. et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat. Commun. 8, 845 https:\/\/doi.org\/10.1038\/s41467-017-00900-1 (2017).","journal-title":"Nat. Commun."},{"key":"11142_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41569-022-00771-0","volume":"20","author":"RM Chakaroun","year":"2023","unstructured":"Chakaroun, R. M., Olsson, L. M. & Backhed, F. The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease. Nat. Rev. Cardiol. 20, 217\u2013235 https:\/\/doi.org\/10.1038\/s41569-022-00771-0 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"11142_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47683-w","volume":"15","author":"C Wasen","year":"2024","unstructured":"Wasen, C. et al. Bacteroidota inhibit microglia clearance of amyloid-beta and promote plaque deposition in alzheimer\u2019s disease mouse models. Nat. Commun. 15, 3872 https:\/\/doi.org\/10.1038\/s41467-024-47683-w (2024).","journal-title":"Nat. Commun."},{"key":"11142_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1997560","volume":"13","author":"K Oliphant","year":"2021","unstructured":"Oliphant, K. et al. Bacteroidota and Lachnospiraceae integration into the gut microbiome at key time points in early life are linked to infant neurodevelopment. Gut Microbes 13, 1997560 https:\/\/doi.org\/10.1080\/19490976.2021.1997560 (2021).","journal-title":"Gut Microbes"},{"key":"11142_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15342-5","volume":"11","author":"FJ Ryan","year":"2020","unstructured":"Ryan, F. J. et al. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease. Nat. Commun. 11, 1512 https:\/\/doi.org\/10.1038\/s41467-020-15342-5 (2020).","journal-title":"Nat. Commun."},{"key":"11142_CR6","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/hep.29623","volume":"67","author":"P Puri","year":"2018","unstructured":"Puri, P. et al. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis. Hepatology 67, 1284\u20131302 https:\/\/doi.org\/10.1002\/hep.29623 (2018).","journal-title":"Hepatology"},{"key":"11142_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/nu13020304","volume":"13","author":"A Baragetti","year":"2021","unstructured":"Baragetti, A. et al. Gut microbiota functional dysbiosis relates to individual diet in subclinical carotid atherosclerosis. Nutrients 13, 304 https:\/\/doi.org\/10.3390\/nu13020304 (2021).","journal-title":"Nutrients"},{"key":"11142_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.cell.2017.03.045","volume":"169","author":"B Lim","year":"2017","unstructured":"Lim, B., Zimmermann, M., Barry, N. A. & Goodman, A. L. Engineered regulatory systems modulate gene expression of human commensals in the gut. Cell 169, 547\u2013558 https:\/\/doi.org\/10.1016\/j.cell.2017.03.045 (2017).","journal-title":"Cell"},{"key":"11142_CR9","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.cell.2024.03.034","volume":"187","author":"Q Nie","year":"2024","unstructured":"Nie, Q. et al. Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway. Cell 187, 2717\u20132734 https:\/\/doi.org\/10.1016\/j.cell.2024.03.034 (2024).","journal-title":"Cell"},{"key":"11142_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01896-9","volume":"12","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Bacteroides uniformis degrades \u03b2-glucan to promote Lactobacillus johnsonii improving indole-3-lactic acid levels in alleviating colitis. Microbiome 12, 177 https:\/\/doi.org\/10.1186\/s40168-024-01896-9 (2024).","journal-title":"Microbiome"},{"key":"11142_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-023-00420-5","volume":"9","author":"Y Yan","year":"2023","unstructured":"Yan, Y. et al. Bacteroides uniformis-induced perturbations in colonic microbiota and bile acid levels inhibit TH17 differentiation and ameliorate colitis developments. NPJ Biofilms Microbiomes 9, 56 https:\/\/doi.org\/10.1038\/s41522-023-00420-5 (2023).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"11142_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add2120","volume":"9","author":"H Morita","year":"2023","unstructured":"Morita, H. et al. Bacteroides uniformis and its preferred substrate, \u03b1-cyclodextrin, enhance endurance exercise performance in mice and human males. Sci. Adv. 9, eadd2120 https:\/\/doi.org\/10.1126\/sciadv.add2120 (2023).","journal-title":"Sci. Adv."},{"key":"11142_CR13","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1093\/eurheartj\/ehab465","volume":"42","author":"LCA Stiekema","year":"2021","unstructured":"Stiekema, L. C. A. et al. Impact of cholesterol on proinflammatory monocyte production by the bone marrow. Eur. Heart J. 42, 4309\u20134320 https:\/\/doi.org\/10.1093\/eurheartj\/ehab465 (2021).","journal-title":"Eur. Heart J."},{"key":"11142_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo, J., Yang, H. & Song, B. L. Mechanisms and regulation of cholesterol homeostasis. Nat. Rev. Mol. Cell Biol. 21, 225\u2013245 https:\/\/doi.org\/10.1038\/s41580-019-0190-7 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"11142_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/CIRCRESAHA.115.304008","volume":"115","author":"S Somanathan","year":"2014","unstructured":"Somanathan, S. et al. AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia. Circ. Res. 115, 591\u2013599 https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.304008 (2014).","journal-title":"Circ. Res."},{"key":"11142_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2024.01.001","volume":"187","author":"G Kim","year":"2024","unstructured":"Kim, G. et al. Gut\u2013liver axis calibrates intestinal stem cell fitness. Cell 187, 914\u2013930 https:\/\/doi.org\/10.1016\/j.cell.2024.01.001 (2024).","journal-title":"Cell"},{"key":"11142_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26787-7","volume":"12","author":"L Goedeke","year":"2021","unstructured":"Goedeke, L. et al. MMAB promotes negative feedback control of cholesterol homeostasis. Nat. Commun. 12, 6448 https:\/\/doi.org\/10.1038\/s41467-021-26787-7 (2021).","journal-title":"Nat. Commun."},{"key":"11142_CR18","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/nm.3949","volume":"21","author":"L Goedeke","year":"2015","unstructured":"Goedeke, L. et al. MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels. Nat. Med. 21, 1280\u20131289 https:\/\/doi.org\/10.1038\/nm.3949 (2015).","journal-title":"Nat. Med."},{"key":"11142_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","volume":"343","author":"JL Goldstein","year":"1990","unstructured":"Goldstein, J. L. & Brown, M. S. Regulation of the mevalonate pathway. Nature 343, 425\u2013430 https:\/\/doi.org\/10.1038\/343425a0 (1990).","journal-title":"Nature"},{"key":"11142_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43690-5","volume":"14","author":"Y Muta","year":"2023","unstructured":"Muta, Y. et al. Enhanced SREBP2-driven cholesterol biosynthesis by PKC\u03bb\/\u03b9 deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis. Nat. Commun. 14, 8075 https:\/\/doi.org\/10.1038\/s41467-023-43690-5 (2023).","journal-title":"Nat. Commun."},{"key":"11142_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.122.059062","volume":"147","author":"A Canfran-Duque","year":"2023","unstructured":"Canfran-Duque, A. et al. Macrophage-derived 25-hydroxycholesterol promotes vascular inflammation, atherogenesis, and lesion remodeling. Circulation 147, 388\u2013408 https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059062 (2023).","journal-title":"Circulation"},{"key":"11142_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32158-7","volume":"13","author":"D Xu","year":"2022","unstructured":"Xu, D. et al. Cholesterol sulfate alleviates ulcerative colitis by promoting cholesterol biosynthesis in colonic epithelial cells. Nat. Commun. 13, 4428 https:\/\/doi.org\/10.1038\/s41467-022-32158-7 (2022).","journal-title":"Nat. Commun."},{"key":"11142_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","volume":"69","author":"L Che","year":"2020","unstructured":"Che, L. et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Gut 69, 177\u2013186 https:\/\/doi.org\/10.1136\/gutjnl-2018-317581 (2020).","journal-title":"Gut"},{"key":"11142_CR24","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2019.10.034","volume":"179","author":"H Yu","year":"2019","unstructured":"Yu, H. et al. GPR146 deficiency protects against hypercholesterolemia and atherosclerosis. Cell 179, 1276\u20131288 https:\/\/doi.org\/10.1016\/j.cell.2019.10.034 (2019).","journal-title":"Cell"},{"key":"11142_CR25","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1059344","volume":"292","author":"ES Istvan","year":"2001","unstructured":"Istvan, E. S. & Deisenhofer, J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292, 1160\u20131164 https:\/\/doi.org\/10.1126\/science.1059344 (2001).","journal-title":"Science"},{"key":"11142_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3945\/an.115.011387","volume":"7","author":"M Pfeuffer","year":"2016","unstructured":"Pfeuffer, M. & Jaudszus, A. Pentadecanoic and heptadecanoic acids: multifaceted odd-chain fatty acids. Adv. Nutr. 7, 730\u2013734 https:\/\/doi.org\/10.3945\/an.115.011387 (2016).","journal-title":"Adv. Nutr."},{"key":"11142_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53144-1","volume":"15","author":"Y Wu","year":"2024","unstructured":"Wu, Y. et al. Galactooligosaccharides and Limosilactobacillus reuteri synergistically alleviate gut inflammation and barrier dysfunction by enriching Bacteroides acidifaciens for pentadecanoic acid biosynthesis. Nat. Commun. 15, 9291 https:\/\/doi.org\/10.1038\/s41467-024-53144-1 (2024).","journal-title":"Nat. Commun."},{"key":"11142_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/bit.28308","volume":"120","author":"N Qin","year":"2023","unstructured":"Qin, N., Li, L., Wang, Z. & Shi, S. Microbial production of odd-chain fatty acids. Biotechnol. Bioeng. 120, 917\u2013931 https:\/\/doi.org\/10.1002\/bit.28308 (2023).","journal-title":"Biotechnol. Bioeng."},{"key":"11142_CR29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s42255-023-00830-x","volume":"5","author":"C Zhan","year":"2023","unstructured":"Zhan, C. et al. Improved polyketide production in C. glutamicum by preventing propionate-induced growth inhibition. Nat. Metab. 5, 1127\u20131140 https:\/\/doi.org\/10.1038\/s42255-023-00830-x (2023).","journal-title":"Nat. Metab."},{"key":"11142_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.chom.2023.11.005","volume":"32","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Bacteroides methylmalonyl-CoA mutase produces propionate that promotes intestinal goblet cell differentiation and homeostasis. Cell Host Microbe 32, 63\u201378 https:\/\/doi.org\/10.1016\/j.chom.2023.11.005 (2024).","journal-title":"Cell Host Microbe"},{"key":"11142_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55845-7","volume":"16","author":"Z Qu","year":"2025","unstructured":"Qu, Z. et al. Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species. Nat. Commun. 16, 638 https:\/\/doi.org\/10.1038\/s41467-025-55845-7 (2025).","journal-title":"Nat. Commun."},{"key":"11142_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01638-3","volume":"11","author":"S Liu","year":"2023","unstructured":"Liu, S. et al. Gut microbes exacerbate systemic inflammation and behavior disorders in neurologic disease CADASIL. Microbiome 11, 202 https:\/\/doi.org\/10.1186\/s40168-023-01638-3 (2023).","journal-title":"Microbiome"},{"key":"11142_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01178-8","volume":"9","author":"Z He","year":"2021","unstructured":"He, Z. et al. Microbiota in mesenteric adipose tissue from Crohn\u2019s disease promote colitis in mice. Microbiome 9, 228 https:\/\/doi.org\/10.1186\/s40168-021-01178-8 (2021).","journal-title":"Microbiome"},{"key":"11142_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41587-020-0603-3","volume":"39","author":"A Almeida","year":"2021","unstructured":"Almeida, A. et al. A unified catalog of 204,938 reference genomes from the human gut microbiome. Nat. Biotechnol. 39, 105\u2013114 https:\/\/doi.org\/10.1038\/s41587-020-0603-3 (2021).","journal-title":"Nat. Biotechnol."},{"key":"11142_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep44845","volume":"7","author":"BJ Jenkins","year":"2017","unstructured":"Jenkins, B. J. et al. Odd chain fatty acids; new insights of the relationship between the gut microbiota, dietary intake, biosynthesis and glucose intolerance. Sci. Rep. 7, 44845 https:\/\/doi.org\/10.1038\/srep44845 (2017).","journal-title":"Sci. Rep."},{"key":"11142_CR36","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3945\/ajcn.117.152702","volume":"105","author":"K Weitkunat","year":"2017","unstructured":"Weitkunat, K. et al. Odd-chain fatty acids as a biomarker for dietary fiber intake: a novel pathway for endogenous production from propionate. Am. J. Clin. Nutr. 105, 1544\u20131551 https:\/\/doi.org\/10.3945\/ajcn.117.152702 (2017).","journal-title":"Am. J. Clin. Nutr."},{"key":"11142_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64960-y","volume":"10","author":"S Venn-Watson","year":"2020","unstructured":"Venn-Watson, S., Lumpkin, R. & Dennis, E. A. Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential? Sci. Rep. 10, 8161 https:\/\/doi.org\/10.1038\/s41598-020-64960-y (2020).","journal-title":"Sci. Rep."},{"key":"11142_CR38","doi-asserted-by":"publisher","first-page":"e1003763","DOI":"10.1371\/journal.pmed.1003763","volume":"18","author":"K Trieu","year":"2021","unstructured":"Trieu, K. et al. Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: a cohort study, systematic review, and meta-analysis. PLoS Med. 18, e1003763 https:\/\/doi.org\/10.1371\/journal.pmed.1003763 (2021).","journal-title":"PLoS Med."},{"key":"11142_CR39","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ajcnut.2023.11.013","volume":"119","author":"YC Chooi","year":"2024","unstructured":"Chooi, Y. C. et al. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. Am. J. Clin. Nutr. 119, 788\u2013799 https:\/\/doi.org\/10.1016\/j.ajcnut.2023.11.013 (2024).","journal-title":"Am. J. Clin. Nutr."},{"key":"11142_CR40","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/sj.ejcn.1602256","volume":"59","author":"A Brevik","year":"2005","unstructured":"Brevik, A., Veierod, M. B., Drevon, C. A. & Andersen, L. F. Evaluation of the odd fatty acids 15:0 and 17:0 in serum and adipose tissue as markers of intake of milk and dairy fat. Eur. J. Clin. Nutr. 59, 1417\u20131422 https:\/\/doi.org\/10.1038\/sj.ejcn.1602256 (2005).","journal-title":"Eur. J. Clin. Nutr."},{"key":"11142_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ajcn\/69.1.22","volume":"69","author":"AE Smedman","year":"1999","unstructured":"Smedman, A. E., Gustafsson, I. B., Berglund, L. G. & Vessby, B. O. Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am. J. Clin. Nutr. 69, 22\u201329 https:\/\/doi.org\/10.1093\/ajcn\/69.1.22 (1999).","journal-title":"Am. J. Clin. Nutr."},{"key":"11142_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1017\/S0007114519003064","volume":"123","author":"I Ampong","year":"2020","unstructured":"Ampong, I., Watkins, A., Gutierrez-Merino, J., Ikwuobe, J. & Griffiths, H. R. Dietary protein insufficiency: an important consideration in fatty liver disease? Br. J. Nutr. 123, 601\u2013609 https:\/\/doi.org\/10.1017\/S0007114519003064 (2020).","journal-title":"Br. J. Nutr."},{"key":"11142_CR43","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","volume":"138","author":"N Yoshida","year":"2018","unstructured":"Yoshida, N. et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation 138, 2486\u20132498 https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.033714 (2018).","journal-title":"Circulation"},{"key":"11142_CR44","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","volume":"8","author":"W Wei","year":"2023","unstructured":"Wei, W. et al. Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid. Nat. Microbiol. 8, 1534\u20131548 https:\/\/doi.org\/10.1038\/s41564-023-01418-7 (2023).","journal-title":"Nat. Microbiol."},{"key":"11142_CR45","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/CIRCULATIONAHA.119.044282","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani, S. S., Smith, S. C. Jr., Stone, N. J. & Grundy, S. M. Secondary prevention for atherosclerotic cardiovascular disease: comparing recent US and European guidelines on dyslipidemia. Circulation 141, 1121\u20131123 https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044282 (2020).","journal-title":"Circulation"},{"key":"11142_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020377","volume":"10","author":"AP Ambrosy","year":"2021","unstructured":"Ambrosy, A. P. et al. Triglyceride levels and residual risk of atherosclerotic cardiovascular disease events and death in adults receiving statin therapy for primary or secondary prevention: insights from the KP REACH study. J. Am. Heart Assoc. 10, e020377 https:\/\/doi.org\/10.1161\/JAHA.120.020377 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"11142_CR47","doi-asserted-by":"publisher","first-page":"e1162","DOI":"10.1161\/CIR.0000000000000638","volume":"139","author":"DM Lloyd-Jones","year":"2019","unstructured":"Lloyd-Jones, D. M. et al. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American heart association and American college of cardiology. Circulation 139, e1162\u2013e1177 https:\/\/doi.org\/10.1161\/CIR.0000000000000638 (2019).","journal-title":"Circulation"},{"key":"11142_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","volume":"400","author":"BK Kim","year":"2022","unstructured":"Kim, B. K. et al. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial. Lancet 400, 380\u2013390 https:\/\/doi.org\/10.1016\/S0140-6736(22)00916-3 (2022).","journal-title":"Lancet"},{"key":"11142_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07590-3","volume":"9","author":"SY Jiang","year":"2018","unstructured":"Jiang, S. Y. et al. Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol. Nat. Commun. 9, 5138 https:\/\/doi.org\/10.1038\/s41467-018-07590-3 (2018).","journal-title":"Nat. Commun."},{"key":"11142_CR50","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1001\/jama.2011.860","volume":"305","author":"D Preiss","year":"2011","unstructured":"Preiss, D. et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305, 2556\u20132564 https:\/\/doi.org\/10.1001\/jama.2011.860 (2011).","journal-title":"JAMA"},{"key":"11142_CR51","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","volume":"370","author":"J Armitage","year":"2007","unstructured":"Armitage, J. The safety of statins in clinical practice. Lancet 370, 1781\u20131790 https:\/\/doi.org\/10.1016\/S0140-6736(07)60716-8 (2007).","journal-title":"Lancet"},{"key":"11142_CR52","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cmet.2023.12.027","volume":"36","author":"J She","year":"2024","unstructured":"She, J. et al. Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner. Cell Metab. 36, 408\u2013421 https:\/\/doi.org\/10.1016\/j.cmet.2023.12.027 (2024).","journal-title":"Cell Metab."},{"key":"11142_CR53","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659\u2013661 https:\/\/doi.org\/10.1096\/fj.07-9574LSF (2008).","journal-title":"FASEB J."},{"key":"11142_CR54","doi-asserted-by":"publisher","DOI":"10.1530\/VB-23-0017","volume":"6","author":"JI van der Vaart","year":"2024","unstructured":"van der Vaart, J. I., van Eenige, R., Rensen, P. C. N. & Kooijman, S. Atherosclerosis: an overview of mouse models and a detailed methodology to quantify lesions in the aortic root. Vasc. Biol. 6, e230017 https:\/\/doi.org\/10.1530\/VB-23-0017 (2024).","journal-title":"Vasc. Biol."},{"key":"11142_CR55","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.cell.2024.02.024","volume":"187","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. A gut-derived hormone regulates cholesterol metabolism. Cell 187, 1685\u20131700 https:\/\/doi.org\/10.1016\/j.cell.2024.02.024 (2024).","journal-title":"Cell"},{"key":"11142_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 https:\/\/doi.org\/10.1186\/s13059-019-1891-0 (2019).","journal-title":"Genome Biol."},{"key":"11142_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0541-1","volume":"6","author":"GV Uritskiy","year":"2018","unstructured":"Uritskiy, G. V., DiRuggiero, J. & Taylor, J. MetaWRAP-a flexible pipeline for genome-resolved metagenomic data analysis. Microbiome 6, 158 https:\/\/doi.org\/10.1186\/s40168-018-0541-1 (2018).","journal-title":"Microbiome"},{"key":"11142_CR58","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.chom.2024.04.017","volume":"32","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor\u20092\u03b1 signaling. Cell Host Microbe 32, 964\u2013979 https:\/\/doi.org\/10.1016\/j.chom.2024.04.017 (2024).","journal-title":"Cell Host Microbe"},{"key":"11142_CR59","doi-asserted-by":"publisher","first-page":"e07999","DOI":"10.7554\/eLife.07999","volume":"4","author":"MA Mitsche","year":"2015","unstructured":"Mitsche, M. A., McDonald, J. G., Hobbs, H. H. & Cohen, J. C. Flux analysis of cholesterol biosynthesis in vivo reveals multiple tissue and cell-type specific pathways. eLife 4, e07999 https:\/\/doi.org\/10.7554\/eLife.07999 (2015).","journal-title":"eLife"},{"key":"11142_CR60","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","volume":"579","author":"S Zhao","year":"2020","unstructured":"Zhao, S. et al. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature 579, 586\u2013591 https:\/\/doi.org\/10.1038\/s41586-020-2101-7 (2020).","journal-title":"Nature"},{"key":"11142_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40943-1","volume":"14","author":"S Hendrix","year":"2023","unstructured":"Hendrix, S. et al. Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans. Nat. Commun. 14, 5181 https:\/\/doi.org\/10.1038\/s41467-023-40943-1 (2023).","journal-title":"Nat. Commun."},{"key":"11142_CR62","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-020-2928-y","volume":"588","author":"XY Lu","year":"2020","unstructured":"Lu, X. Y. et al. Feeding induces cholesterol biosynthesis via the mTORC1\u2013USP20\u2013HMGCR axis. Nature 588, 479\u2013484 https:\/\/doi.org\/10.1038\/s41586-020-2928-y (2020).","journal-title":"Nature"},{"key":"11142_CR63","doi-asserted-by":"publisher","first-page":"e1900035","DOI":"10.1002\/mnfr.201900035","volume":"63","author":"S Kuntz","year":"2019","unstructured":"Kuntz, S. et al. Metabolic fate and distribution of 2\u2032-fucosyllactose: direct influence on gut microbial activity but not on brain. Mol. Nutr. Food Res. 63, e1900035 https:\/\/doi.org\/10.1002\/mnfr.201900035 (2019).","journal-title":"Mol. Nutr. Food Res."},{"key":"11142_CR64","doi-asserted-by":"publisher","first-page":"e2100045","DOI":"10.1002\/mnfr.202100045","volume":"65","author":"S Rudloff","year":"2021","unstructured":"Rudloff, S. et al. Fucose as a cleavage product of 2\u2032 fucosyllactose does not cross the blood\u2013brain barrier in mice. Mol. Nutr. Food Res. 65, e2100045 https:\/\/doi.org\/10.1002\/mnfr.202100045 (2021).","journal-title":"Mol. Nutr. Food Res."},{"key":"11142_CR65","doi-asserted-by":"publisher","first-page":"e2217831120","DOI":"10.1073\/pnas.2217831120","volume":"120","author":"Y Yogev","year":"2023","unstructured":"Yogev, Y. et al. Limb girdle muscular disease caused by HMGCR mutation and statin myopathy treatable with mevalonolactone. Proc. Natl Acad. Sci. USA 120, e2217831120 https:\/\/doi.org\/10.1073\/pnas.2217831120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"11142_CR66","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ajhg.2023.04.006","volume":"110","author":"JA Morales-Rosado","year":"2023","unstructured":"Morales-Rosado, J. A. et al. Bi-allelic variants in HMGCR cause an autosomal-recessive progressive limb-girdle muscular dystrophy. Am. J. Hum. Genet. 110, 989\u2013997 https:\/\/doi.org\/10.1016\/j.ajhg.2023.04.006 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"11142_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30060-w","volume":"13","author":"AG Trub","year":"2022","unstructured":"Trub, A. G. et al. Statin therapy inhibits fatty acid synthase via dynamic protein modifications. Nat. Commun. 13, 2542 https:\/\/doi.org\/10.1038\/s41467-022-30060-w (2022).","journal-title":"Nat. Commun."},{"key":"11142_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk5382","volume":"384","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1\u2013CYP11A1 interaction. Science 384, eadk5382 https:\/\/doi.org\/10.1126\/science.adk5382 (2024).","journal-title":"Science"},{"key":"11142_CR69","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1021\/acssynbio.1c00543","volume":"11","author":"L Zheng","year":"2022","unstructured":"Zheng, L. et al. CRISPR\/Cas-based genome editing for human gut commensal Bacteroides species. ACS Synth. Biol. 11, 464\u2013472 https:\/\/doi.org\/10.1021\/acssynbio.1c00543 (2022).","journal-title":"ACS Synth. Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11142-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11142-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11142-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:10:12Z","timestamp":1792663812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11142-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":69,"alternative-id":["11142"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-11142-x","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.M. is an inventor on a pending patent application (CN202510500448.8) covering the use of PA for the prevention or treatment of atherosclerosis. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}